Cannabinoids in Autism and Fragile X Syndrome: Value-Based Treatment Revolution Ahead?-Juniper Publishers
JUNIPER PUBLISHERS - OPEN ACCESS JOURNAL OF INTELLECTUAL & DEVELOPMENTAL DISABILITIES Introduction Cannabis has a long history in Central and South Asia, as it was used to produce hemp fibre for rope, clothing and paper, but was also consumed both for recreational and medicinal purposes. The two major neuro active components in cannabis are the psychoactive A9-tetrahydro-cannabinol (A9-THC) and the non-psychoactive cannabidiol (CBD). Recent years have seen a resurgence in interest in the therapeutic potential of compounds derived from cannabis, due to significant advances in our understanding of cannabis ingredients and endogenous brain cannabinoid (ECB) system, which consists of G-protein- coupled cannabinoid (CB) receptors, endocannabinoids such as N-Arachidonoylethanolamide (Anandamide) and 2-Arachidonoylglycerol (2-AG), synthetic and degradative enzymes, and transporters. Common medical conditions for which marijuana is allowed in the US (...